Tech Company Financing Transactions
Bryleos Funding Round
On 6/13/2023, Bryleos raised $5 million in Seed funding from private investors.
Transaction Overview
Company Name
Announced On
6/13/2023
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Seed
Investors
private investors (Eddie Jordan)
Proceeds Purpose
The company intends to use the funds to develop its novel oral composition of NAD+, BNAD101.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Johnson City, TN Undisclosed
USA
Johnson City, TN Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Overview
At Bryleos, we are breaking barriers in the clinical-stage therapeutics landscape. As a woman-owned and women-led company, we embrace a bold vision for the future of healthcare. We harness the power of a systems approach to tackle the burden of costly chronic diseases head-on. Using breakthrough technology, Bryleos has developed a patent-pending oral composition of NAD+ with the potential to enable optimal function of every cell.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Wendy Komac
Chief Financial Officer
Filip Pinter
Browse more venture capital transactions:
Prev: 6/13/2023: Collectibles.com venture capital transaction
Next: 6/13/2023: Tagboard venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs